A two-phase epigenome-wide four-way gene-smoking interaction study of overall survival for early-stage non-small cell lung cancer Mol Oncol
Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin's lymphoma and characterization of the loss of the target antigen J Immunother Cancer
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups CANCERS
Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study Eur J Cancer
The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045 JNCI-J NATL CANCER I
An Integrated Neuromuscular Training Intervention Applied in Primary School Induces Epigenetic Modifications in Disease-Related Genes: A Genome-Wide DNA Methylation Study SCAND J MED SCI SPOR
Measurable residual disease by mass spectrometry and next-generation flow to assess treatment response in myeloma Blood
First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas MOL THER NUCL ACIDS